September 03, 2010
Cough-Syrup Abuse by Kids May Draw FDA Restrictions
Pfizer Inc.'s Robitussin and Johnson & Johnson Tylenol Cough may be reviewed for possible U.S. dispensing restrictions because of increasing signs of abuse and injuries among adolescents. Non-medical use of dextromethorphan, a common cough suppressant approved since 1958, accounted for an estimated 7,988 emergency room visits in 2008, up from 4,634 in 2004, according to a U.S. government report yesterday. A Food and Drug Administration advisory panel will meet Sept. 14 to discuss whether the medicine should be a controlled substance.Click Here For The Full Story......
Latest Pro-Life News and Headlines:
Freedom of Speech | Politics | Abominations
Court News Report | Family Topic Directory | Ron Paul Headlines



